Market Research Blog – Page 1757 – New Product Development

Medical Protective Equipment Market is expected to grow by 2033 by region, end user, usage, and product type

The global Medical Protective Equipment Market is projected to experience significant growth, according to a recent analysis by Future Market Insights (FMI). This market, valued at USD 21.3 billion in 2023, is expected to reach a substantial USD 52.8 billion by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 9.5%.

The medical protective equipment market is being driven by the surging demand from healthcare facilities. Key players in the market have concentrated their focus on enhancing their product offerings in face masks, face shields, gowns, and gloves. The companies are also emphasizing on expanding the production capacities of the product to contribute towards the overall market growth.

The stringent governmental norms and heightened concerns towards health and safety are projected to induce end users to invest in medical protective equipment. Thereby, driving the medical protective equipment industry forward. Additionally, medical protective equipment helps decrease the exposure to hazards that can lead to serious health issues. Growing awareness regarding the benefits of shielding via medical protective equipment is projected to accelerate market expansion in the upcoming years.

Get a Full PDF Sample Copy of the Latest Reports

Since maintenance of hand hygiene is considered important to avoid getting infected by infectious diseases, the demand for gloves is surging significantly. Also, medical gloves are used to safeguard the wearer as well as other patients from spreading the infection or illness during medical procedures or examinations. Increasing surgical procedures over the forthcoming years is projected to boost the sales of medical gloves, thus shaping the medical protective equipment industry.

Key Highlights of the Medical Protective Equipment Market:

The United States holds a large share of the medical protective equipment market. The same trend is projected to be followed in the forthcoming years, as the country is projected to attain US$ 13.8 billion by 2033. The estimated CAGR for the forecast period is 7%.
In the Asia Pacific, China is expected to secure a significant position in the forecast period. The country is anticipated to reach US$ 2.9 billion by 2033, registering a CAGR of 11% in the meantime.
The United Kingdom is predicted to garner market revenue of US$ 2.2 billion by 2033. The market is predicted to expand at a CAGR of 9.5% over the forthcoming years.
The gloves segment is expected to exhibit a CAGR of 8.9% over the forecast period. Growing demand for surgical disposable gloves approved by FDA is propelling the gloves segment forward.

News Featuring Market Developments by Key Players of Medical Protective Equipment Solutions:

In March 2022, Ansell Ltd., a leading provider of personal protective equipment, joined the global players working in the rubber glove industry to establish Responsible Glove Alliance (RGA). The role of RGA is to ensure protection of workers susceptible to forced labor in supply chains, especially within medical supply industries. The initial focus of RGA would be manufacturing industry of rubber glove in Malaysia. This is due to the fact that Malaysia is world’s leading producer of rubber gloves, and relies extensively on migrant labor.
In March 2022, Dynarex Corporation, extended its durable medical equipment (DME) portfolio to meet the surging demands from long-term care and home-care marketplaces. The offerings of DME includes premium solutions for a range of requirements, such as home care beds, lifts and slings, mattresses, mobility, wheelchairs, etc. and long-term care.
In February 2022, Kimberly-Clark Worldwide, Inc. officially revealed its innovative ICON dispenser collection. These dispensers provide design customization, along with patented technology to supply a 99.99% jam-free, more efficient, virtually noise-free paper towel dispensing experience.

Click here today to Buy your Full Report!

Medical Protective Equipment Market by Category

By Product Type:

Gloves
Protective Clothing
Gowns
N95 Respirators
Surgical Masks
Goggles
Face Shields
Head Cover
Shoes Covers

By Usage:

Disposable
Non-disposable

By End User:

Hospitals
NGO’s/ Government Organization
Ambulatory Surgical Centers
Specialized Clinics
Diagnostic and Research Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Recombinant Vaccines Market By Product Type, Hospitals, Retail Pharmacies, Private Clinics & Region Forecast 2018 to 2028

The Recombinant Vaccines Market is poised for significant growth, projected to reach a promising revenue of USD 2,440.6 million by the year 2028. This upward trajectory is fueled by a commendable Compound Annual Growth Rate (CAGR) of 6.1%. This signifies a strong and steady market expansion, reflecting both increasing demand for recombinant vaccines and advancements in the field.

Recombinant vaccines, which are comparatively safer and more affordable, are gaining significant traction on a global scale during this decade. With an increasing emphasis on preventive healthcare, vaccines are gaining momentum worldwide, including in developing economies that continue to grapple with a substantial demand-supply gap, resulting in a significant shortage of vaccines. Nonetheless, several prominent non-profit organizations are continually initiating funding collaborations to enhance the accessibility of crucial vaccines in developing countries.

Get a Sample Copy PDF of This Report Now!

Key Dynamics Analysis Evaluates the Role of Collaborative Activities and R&D

Against the backdrop of how Sanofi’s acquisition of Protein Sciences in 2017 has been boosting the former’s Flubok (recombinant vaccines for flu) manufacturing capacity, several players in the recombinant vaccines space are strategizing mutual alliances in coming years. Strategic collaborations between leading players in the recombinant vaccines space are likely to provide a strong impetus to the overall market growth.

Moreover, according to WHO, the growing prevalence of rare disease instances such as Ebola, Crimean Congo, MERS, hemorrhagic fever, Marburg, Lassa Fever, Nipah, SARS coronavirus diseases, and Rift Valley Fever is attracting R&D interests of recombinant vaccine manufacturers, thereby pushing growth of the market shortly

FMI Study Positions Western Europe as Growth Engine of Recombinant Vaccines Landscape

Western Europe currently represents just under 1/3rd share of the global market revenue, attributed to growing government support for vaccine development and vaccination campaigns. The strong presence of key market players in this region and their increasing investments in the R&D of recombinant vaccines further accentuate Western Europe’s top-performing spot.

The report projects impressive growth prospects for Asia Pacific and Japan in the coming years. However, APAC is especially portrayed as lucrative owing to dramatically growing healthcare spending and an expanding target population that struggles with highly unmet clinical needs, despite growing consumer awareness about vaccination merits.

Mature regional markets in North America and Europe remain differentiated due to the effective presence of leading biopharmaceutical companies that boast of GMP-certified sterile manufacturing facilities, contributing significantly towards the revenue growth of the recombinant vaccines market in these regions.

Segmental Analysis Reveals Neck-on-Neck Competition between Subunit and Attenuated Vaccine Types

Based on the recombinant vaccines market assessment by type, subunit recombinant vaccines currently hold the largest value share but are likely to lose a bit of it to attenuated recombinant vaccines. Both segments collectively cover around 90% share of the total market revenue.
Applications of recombinant vaccines in human vaccination continue to reflect maximum attractiveness over veterinary applications. A majority of the total market revenue is contributed by recombinant vaccines for humans, as indicated by the report.
Private clinics and dispensaries remain the most preferred channel for vaccine distribution, followed by pharmacies. Hospital pharmacies hold a larger share than retail pharmacies, though the latter is poised for promising expansion in coming years.

Top Two Players Represent a Whopping 80% Market Value Share, Concludes Competition Analysis

According to the FMI study, GlaxoSmithKline plc and Merck & Co., Inc. collectively account for more than 80% revenue share in the recombinant vaccines marketplace, keeping the landscape highly consolidated. While the former primarily focuses on strategic collaborations, the latter strategizes new product launches for an expanded market share.

GSK’s candidate vaccine launched in 2017 claims to prevent pulmonary TB in HIV-negative adult patients.
Merck announced the three studies of the first phase of its investigational pneumococcal vaccine, early in 2018.

Competition tracking uncovers a few more important insights that can potentially direct strategy-building efforts of competitors in the recombinant vaccines market at a global level.

New market entry aspirants are prominently opting for the adoption of mammalian protein expression systems in recombinant vaccine manufacturing that accelerate the entire production process.
Established players in the recombinant vaccines landscape are prioritizing the development of new variants of existing vaccines.
Contractual alliances with non-profit organizations are likely to earn higher profit shares for manufacturing leaders in the recombinant vaccines market.

Get a Full Report for Details Insights- Purchase Now!

Segmentation

The report on the recombinant vaccines market provides salient information on market players. The recombinant vaccines market is segmented by region, product type, application, and distribution channel, to analyze segment-wise growth of the recombinant vaccines market. Based on regions, the recombinant vaccines market is segmented into seven regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

The recombinant vaccines market by product type is segmented into subunit recombinant vaccines, attenuated recombinant vaccines, and vector recombinant vaccines. By application, the recombinant vaccines market is segregated into human, and veterinary recombinant vaccines. By distribution channel, the recombinant vaccines market is segregated into hospitals, private clinics & dispensaries, retail pharmacies & others.

About Future Market Insights (FMI)

Contact Us:

Laparoscopic Device Market Projected to Exceed USD 20.5 Billion by 2034 at a 4.2% of CAGR

The global laparoscopic device market is poised for significant growth, with projections indicating a market value of USD 13.59 billion in 2024 and anticipated to expand at a moderate compound annual growth rate (CAGR) of 4.2% through 2034. By the end of this forecast period, the market is expected to surpass USD 20.5 billion, driven by increasing prevalence of obesity and advancements in laparoscopic surgical techniques.

Laparoscopic devices play a crucial role in minimally invasive surgery, offering patients reduced recovery times, minimized surgical trauma, and improved post-operative outcomes. These devices are integral in various surgical procedures across specialties such as gynecology, urology, and gastrointestinal surgeries, contributing to enhanced patient care and healthcare efficiency.

Laparoscopic devices, known for their precision and reduced recovery times, are becoming essential tools in the fight against obesity-related health issues. As more patients and healthcare providers turn to these advanced surgical options, the market is expected to see sustained growth.

Request a Sample Copy of This – Report Now

The market for laparoscopic devices is anticipated to expand at a 5.8% compound annual growth rate (CAGR) from US$ 12.3 billion in 2022 to US$ 18.4 billion by 2029.

Over the next ten years, there is expected to be a significant growth in the laparoscopic devices industry. due to the quick rise in the demand for minimally invasive surgical treatments as well as the growing potential for use in colorectal and bariatric surgery.

According to the report, the laparoscopic devices market is anticipated to grow over the coming years due to a combination of increased foreign direct investment (FDI) in developing countries and marketing and promotional initiatives.

Key Takeaways :

Steady demand growth is observed for bariatric surgery, in line with the expanding obese population coupled with wide-scale adoption rate of minimally invasive techniques. Sales of laparoscopic devices for bariatric surgery will surpassing that for colorectal surgery towards the end of projection period.

Sales of laparoscopic devices will be higher in North American countries. The availability of skilled surgeons and several advantages of minimally invasive surgery over open surgery are few factors driving the market of laparoscopy devices.

The key players in the laparoscopic devices market are focusing on technologically advanced surgical systems with improved dexterity, ergonomics, and visual enhancements that provide advantages to surgeons and minimize the risk for patients while undergoing laparoscopic procedures.

Increasing consumer base along with modern amenities in the healthcare sector is expected to drive sales of laparoscopic devices in developing regions.

Rising private and foreign investments in the laparoscopic devices market and adoption of subscription commerce marketing model by market players are anticipated to shape the overall laparoscopic devices market.

Customization – Available

Key Companies Profiled :

Olympus Corporation

Braun Melsungen AG

Intuitive Surgical Inc.

Medtronic plc.

Stryker Corporation

Smith & Nephew Plc

CareFusion Corporation

Ethicon US, LLC

KARL STORZ GmbH & Co. KG

Richard Wolf GmbH

Endocontrol SA

Tekno-Medical Optik Surgery GmbH

Unlock In-Depth Market Insights – Purchase Now to Access

Laparoscopic devices market by Category :

By Product:

Direct Energy System Devices
Trocars/Access Device
Internal Closure Devices
Laparoscopes
Hand Access Instruments
Insufflation Devices
Robotic Assisted Surgical System

By Therapeutic Application:

Bariatric Surgery
Colorectal Surgery
General Surgery
Gynecological Surgery
Urological Surgery

By End User:

Hospitals
Ambulatory Surgical Centers
Clinics

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Narcolepsy Treatment Market Report including opportunities, segmentation, and upcoming trends, projected through 2028

New hope for those living with narcolepsy! The global Narcolepsy Treatment Market, valued at USD 4.77 billion in 2022, is projected to reach USD 6.67 billion by 2028. This signifies a steady growth trajectory with a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period (2022-2028).

To Get a Sample Copy of the Report visit

Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:

Strong distribution pipeline of narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
The prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
The prevalence of sleep apnea is more severe in developing countries due to the lack of skilled physicians

In terms of key forward market strategies, the primary objective of manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets and to solidify their market position.

Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market

Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low-cost generic versions of patented drugs, strategic partnerships, and acquisitions with pave the way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused on introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospitals and retail, drug stores, and e-commerce. Sales through e-commerce distribution channeare is expected to contribute a significant revenue share in the global narcolepsy treatment market.
FMI has also noted an increasing focus on the reformulation of well-known products and combinations, by manufacturers in North America to achieve higher sales and wide penetration.

There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids. Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home-based unit, further reducing the dependency on OTC pills and prescription drugs.

While explaining the growth trajectory of the narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand for narcolepsy treatment through 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations, and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.

Critical Market Restrainers

Although the narcolepsy market is expanding at a robust CAGR, long waiting times for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aid medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.

Why Future Market Insights?

Comprehensive analysis of evolving purchase patterns across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers, and acquisitions lined up in upcoming years
Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Get Full Access to the Report- Purchase Now!

Key Market Segments Covered in Narcolepsy Treatment Market Research

By Product:

Narcolepsy Treatment Drugs
- Modafinil
- Sodium Oxybate
- Armodafinil
- Others
Devices
- CPAP Devices
- BiPAP Devices
- APAP Devices

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
e-commerce
Drug Stores
Others

By Region:

North America
Latin America
Europe
APAC
MEA

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Animal Model Market Set to Reach USD 3,476.8 Million by 2034 at a 6% of CAGR

The global animal model market is poised for substantial growth, with estimates indicating a revenue of approximately USD 1,943.3 million in 2024 and projected to expand at a moderate compound annual growth rate (CAGR) of 6% over the next decade. By the end of this forecast period, the market is forecasted to reach nearly USD 3,476.8 million, driven by the unique advantages of animal models in biomedical research.

Animal models play a pivotal role in biomedical and pharmaceutical research due to their shorter life cycles, high genotype resemblance to humans, and ease of testing in controlled laboratory environments. These characteristics enable scientists and researchers to study disease mechanisms, test new therapies, and evaluate drug efficacy and safety profiles before clinical trials.

According to the latest animal model demand analysis report, the market’s growth is fueled by increasing research activities and the need for effective preclinical models in drug development. As the scientific community continues to seek reliable and efficient methods for medical testing, the demand for animal models is expected to rise significantly.

Request a Sample Copy of This – Report Now

Animal models play a crucial role in various stages of drug development, from initial discovery to preclinical and clinical trials. Their use enables researchers to understand biological mechanisms, test the efficacy and safety of potential treatments, and evaluate disease progression and therapeutic interventions.

Key Takeaways from the Animal Model Market Study Report:

The market in North America is expected to account for over 40% of the global market share in 2024, followed by Europe.
The United States creates the most demand for preclinical animal models in North America and is poised to advance further with a 6.7% CAGR through 2034.
Germany is expected to continue to be the most lucrative market for animal models in Europe, exhibiting a growth rate of 8.2% through 2034.
The United Kingdom is another notable market for the use of laboratory animals, which is likely to exhibit a 6.6% CAGR till 2034.
China is the leading supplier of animal models for preclinical research in Asia and is expected to witness a 6.1% CAGR through 2034.

Competitive Landscape for the Animal Model Market Participants:

The competition in the animal model industry is highly concentrated, and many contemporary participants are focused on the rat and mouse model segment. However, the approval and adoption of many other animal species, like pigs or non-human primates, is expected to diversify the market by increasing animal model suppliers.

“Rising demand for biomedical research animals and their increased use in the development of personalized medicine has created new opportunities for existing animal model suppliers. Further, more government support in the form of funding and subsidies for supplying laboratory animals in pharmacological studies has encouraged many start-ups in recent years,” – says a lead analyst at FMI.

Key Players Profiled in the Animal Model Market Report:

Charles River Laboratories International, Inc.
Horizon Discovery Group plc.
The Jackson Laboratory
Taconic Biosciences, Inc.
Genoway SA
Eurofins Scientific SE
Crown Bioscience, Inc.
Envigo CRS SA
Transposagen Biopharmaceuticals, Inc.

Customization – Available

Key Segments Covered by Animal Model Industry Survey Report:

By Species Type:

Rats
Mice
Guinea Pigs
Rabbits
Monkeys
Dogs
Pigs
Cats
Other Species

By Application:

Basic and Applied Research
Drug Discovery and Development
Other Applications

By End User:

Academic & Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Other End Users

By Region:

North America
Latin America
Europe
East Asia
South Asia and Pacific
Middle East and Africa (MEA)

Get Full Market Analysis Now – Purchase The Report

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Amniotic Membrane Market is anticipated to expand gradually at a 4.2% CAGR and reach USD 2.28 Billion by 2034 | FMI

The Amniotic Membrane Market is experiencing a surge, fueled by its expanding role in various healthcare applications. According to a recent market analysis, the market is projected to reach a value of USD 2.28 billion by 2034, reflecting a steady Compound Annual Growth Rate (CAGR) of 4.2% from 2024 to 2034. This growth highlights the increasing adoption of amniotic membrane products across diverse medical fields.

The surge in the amniotic membrane market is attributed to its increasing demand driven by its therapeutic potential in various medical applications. Key areas benefiting from amniotic membrane applications include wound healing, ophthalmology, and tissue regeneration.

Request a Sample Copy of This Report Now.

The population of all age groups has emerged as a prominent consumer base, characterised by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries. This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic about increasing amniotic membrane transplants and increasing demand for amniotic membrane products worldwide, particularly in North American countries. It is more than likely that over the next four to five years, the companies focus on developing innovative products and designing market-level strategies to leverage the potential opportunities emerging in parallel with the growing human population with various chronic diseases.

Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membranes and lyophilized amniotic membranes evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.

The global amniotic membrane market has been segmented based on product type, application, end-user and region. Globally, cryopreserved amniotic membrane is the most attractive segment from manufacturers’ point of view. Cryopreserved amniotic membrane is majorly used in ocular surface eye surgery owing to its positive effect on wound healing due to its anti-inflammatory properties. Among all end users of amniotic membranes, high demand for amniotic membranes is expected to come from the hospital segment due to the rising application of amniotic membranes in advanced surgical healing.

By volume

The global amniotic membrane market is expected to expand at 11.4% over the forecast period of 2018–2028. With nearly 43% market value share, North America dominated the global amniotic membrane market in 2017, partly due to the penetration of newly approved products in the U.S. Western Europe, the second largest market globally, with the U.K., France and Germany being countries with high growth rates., is expected to gain 110 BPS in its market share over 2018–2028. APEJ is expected to be the third-largest market for amniotic membranes. APEJ and China collectively are expected to contribute over 15% share in the global market by 2028 over 2018.

The market for amniotic membranes is highly consolidated with the top 5 players contributing over 60% of the revenue share in 2017.

Examples of some of the key players identified in the Amniotic Membrane Market are Integra

LifeSciencesm Inc.
MiMedx Group, Inc.
Alliqua BioMedical, Inc.
Skye Biologics Inc.
Katena Products, Inc.
Tissue-Tech Inc.
Amnio Technology, LLC
Applied Biologics LLC
Human Regenerative Technologies, LLC

Depth of research, along with proper documentation and statistical validation are factors that could determine a player’s success in the global amniotic membrane market

Some of the key points identified in the Amniotic Membrane Market are:

Market Valuation: The global amniotic membrane market is estimated to be US$ 1,510.6 million in 2024.
Future Projections: By 2034, the market is forecasted to exceed a valuation of US$ 2,279.5 million, recording a CAGR of 4.2%.
Therapeutic Potential: Amniotic membrane demand is primarily fueled by its therapeutic potential, particularly in wound healing, ophthalmology, and tissue regeneration.

Access Exclusive Market Insights – Purchase Now!

Key Segments of Amniotic Membrane Market Survey

by Product Type:

Cryopreserved Amniotic Membranes
Lyophilized Amniotic Membranes

by Application:

Surgical Wounds
Ophthalmology
Others

by End User:

Amniotic Membrane Treatment in Hospitals
Amniotic Membrane Treatment in Specialized Clinics
Amniotic Membrane Treatment in Ambulatory Surgical Centres
Amniotic Membrane Treatment in Academic Research Centres

by Region:

North America Amniotic Membranes Market
Latin America Amniotic Membranes Industry
Europe Amniotic Membranes Market
East Asia Amniotic Membranes Industry
South Asia & Pacific Amniotic Membranes Market
Middle East & Africa (MEA) Amniotic Membranes Industry

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Massage Therapy Service Market is Anticipated to Reach US$ 146.13 Billion by 2034

The massage therapy service market is projected to be valued at US$65.23 billion in 2024, with massage therapy services expected to experience a promising compound annual growth rate (CAGR) of 8.4% from 2024 to 2034. By 2034, the global market is anticipated to reach US$146.13 billion.

Due to mental tiredness and stress caused by frantic lifestyles, consumers spend more money on soothing and rejuvenating services such as massage and spas. An increasing desire for revitalizing and soothing therapies to purify the system will keep a variety of massage therapies in demand.

Massage therapy demand is anticipated to remain elevated due to the growing urge to maintain a psychologically and physically healthy lifestyle. Furthermore, the frequency of chronic illnesses is likely to increase the demand for massage services internationally. The spike in demand for system decontamination, stress management, and chronic illness treatments is likely to substantially boost the worldwide massage market.

Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-15720

Further, aging population is spending more on non-surgical therapies to improve their physical and mental well-being. Relaxation of the system, relaxation of body cells and tissues, and anti-stress therapy will drive global demand for massage therapies. During the forecast period, such factors are likely to contribute to the expansion of the worldwide massage market.

Growth Drivers:

Increasing Awareness of Health Benefits: Growing awareness among consumers about the therapeutic benefits of massage therapy, including stress reduction, pain management, and improved circulation, is driving demand for massage services.
Rising Disposable Income: As disposable income levels rise, individuals are more willing to spend on wellness and relaxation services, including massages, contributing to the growth of the market.
Expanding Healthcare Industry: Integration of massage therapy into mainstream healthcare practices, including hospitals, clinics, and wellness centers, is broadening the market’s reach and increasing demand for professional massage services.
Aging Population: The aging population is more prone to musculoskeletal issues, chronic pain, and stress-related ailments, creating a sustained demand for massage therapy services among this demographic segment.
Technological Advancements: Integration of technology in massage therapy equipment and techniques, such as electric massage chairs, handheld massagers, and online booking platforms, is enhancing the accessibility and convenience of massage services, attracting more customers.

Industry Restraints:

Regulatory Challenges: Compliance with varying state regulations, licensing requirements, and insurance coverage limitations poses challenges for massage therapists and businesses, potentially hindering market growth and expansion.
High Competition: The massage therapy market is highly fragmented with numerous independent practitioners and spa chains, leading to intense competition for market share and pricing pressures.
Economic Uncertainty: Economic downturns or periods of instability may result in reduced consumer spending on discretionary services like massage therapy, impacting the market’s growth potential.
Staffing and Training Issues: Recruiting and retaining skilled massage therapists, along with the costs and time associated with training, can pose challenges for businesses aiming to maintain service quality and meet customer demand.
Public Perception and Misconceptions: Addressing public misconceptions or stigma surrounding massage therapy, such as concerns about professionalism, privacy, or misconceptions about its efficacy, may require educational efforts and marketing strategies to overcome, potentially affecting market growth.

Gain Immediate Access to Detailed Market Insights: https://www.futuremarketinsights.com/checkout/15720

Key Takeaways from the Massage Therapy Services Market Study

Women’s segment is anticipated to boost the growth of the massage therapy services market due to increasing trend of beauty and grooming worldwide.
By service type, the deep tissue massage segment is expected to gain revenue over the upcoming decade.
In terms of sales channel, the online booking segment is expected to witness impressive growth during the projection period.
The U.S. and the U.K. are expected to account for lion’s share in North America and Europe market, respectively.

Who is winning?

Leading manufacturers of massage therapy services market are focused on aggressive promotional strategies, advertisements, and new services launches that have driven sales growth of massage therapy services market globally.

Major players present in the massage therapy services market

Massage Envy
Hand and Stone Massage and Facial Spa
Elements Massage
Massage Heights
The Woodhouse Day Spa
MassageLuXe
Spavia
LaVida Massage
Massage Green Spa
InterContinental Hotels Group plc
siam wellness group
Other (on request)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Handheld Ultrasound Scanner Market to Reach USD 750.3 Million by 2034 at a 3.90% of CAGR

The global handheld ultrasound scanner market is on a trajectory of significant growth, with projections indicating a market size of USD 511.8 million in 2024 and anticipated to reach USD 750.3 million by 2034. This growth reflects a steady compound annual growth rate (CAGR) of 3.90% over the forecast period, driven by technological advancements and expanding applications in medical diagnostics.

Handheld ultrasound scanners offer portability, convenience, and real-time imaging capabilities, revolutionizing point-of-care diagnostics across healthcare settings. These devices enable healthcare professionals to conduct quick assessments and diagnostic evaluations, enhancing patient care efficiency and accessibility to ultrasound technology.

As healthcare providers and patients alike recognize the benefits of quick and accurate diagnostics, the handheld ultrasound scanner market is set to experience continuous expansion. This trend highlights the pivotal role of technological innovation in enhancing patient care and improving healthcare outcomes globally.

Request a Sample Copy of This – Report Now

Technological developments have resulted in the development of portable ultrasound scanners that are easy to use and can be coupled via Bluetooth or Wi-Fi with smartphones or tablets. Smooth photo transmission to medical institutions is made possible by these features, which also improve user-friendliness and expedite treatment planning and diagnostics.

Global Handheld Ultrasound Scanners Market: Dynamics

The global market for handheld ultrasound scanners is growing due to a number of factors, including technological advancements in medical imaging devices, an increase in non-radiologist use of these devices, the benefits of international trade agreements, an increase in the import of imaging diagnostics systems, an increase in healthcare expenditures, a rise in the number of medical device manufacturers, an increased focus on inorganic growth by healthcare companies, innovations and developments in ultrasound scanning technology, modernization of healthcare investment, changing healthcare patterns, an increase in the prevalence of chronic disorders, and the adoption of distribution and licensing agreements by various players to increase product penetration. However, there are limitations due to things like non-standardized product pricing, growing consumption taxes, a shortage of qualified specialists, a lack of research and development in some fields, and medical device counterfeiting to the growth of the global handheld ultrasound scanners market.

Global Handheld Ultrasound Scanners Market: Segmental Highlights

The global handheld ultrasound scanners market is segmented by end user (hospitals, diagnostic centres, ASCs and others), modality type (wired scanners and wireless scanners), display type (black and white display and colour display) and region (North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East and Africa).

In 2021, the North America handheld ultrasound scanners market was dominated by the US, which held a share of approximately 86.6%. Over the forecast period, the U.S. market is expected to experience a stable growth rate of 10.2%, which is considered lucrative. Despite the fact that the majority of maternal deaths in the U.S. could be prevented, they have been increasing since 2000.
The global handheld ultrasound scanners market was predominantly led by wired modalities in 2021, accounting for a share of approximately 83.6%. According to FMI’s projections, this segment is expected to continue its growth trajectory with a steady CAGR of about 8.6% throughout the forecast period.
In 2021, colored display held the majority of revenue share in the global handheld ultrasound scanners market at 60.4%. The segment is expected to experience gradual growth with a CAGR of 10.0% throughout the evaluation period. Colored display ultrasound scanners are known for their ability to capture images with accuracy and precision, which may contribute to their popularity and continued growth in the market.
The hospital segment accounted for a significant revenue share of 37.2% in the handheld ultrasound scanners market in 2021. Going forward, the segment is expected to continue its growth trajectory with a gradual CAGR of 9.9% during the forecast period. This can be attributed to the increasing demand for handheld ultrasound scanners in hospitals, which can provide healthcare professionals with real-time images for diagnosis and monitoring purposes.

Customization – Available

Global Handheld Ultrasound Scanners Market: Competition Analysis

The global handheld ultrasound scanners market research report includes company profiles of key players involved in the daily operations of handheld ultrasound scanners. Koninklijke Philips N.V., GE Healthcare, Fujifilm SonoSite, Inc., Clarius Mobile Health, Signostics Limited, Sonoscanner SARL, Mobisante, Inc., Terason (Teratech corp.), Shenzhen Sunway Medical Device Co., Ltd., Shenzhen WELLD Medical Electronics Co., Ltd., Shenzhen Landwind Industry Co., Ltd., Healcerion, Co., Ltd., Meditech Equipment Co.,Ltd (Meditech Group), Sino-Hero(Shenzhen) Bio-Medical Electronics Co., Ltd., Caresono Technology CO., Ltd., Sonostar Technologies Co., Ltd., DGH Technology, Inc., and Xuzhou Palmary Electronics Co., Ltd., are the key players analysed in the global handheld ultrasound scanners market research study.

Key Segments Covered in Handheld Ultrasound Scanners Market Report

By Modality:

Wired
Wireless

By Display:

Black & White Display
Color Display

By End User:

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Others

Gain Full to Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Anaesthesia Machines Market sales, demand, analysis, statistics for forecast period 2023 to 2033 | FMI

The Anaesthesia Machines Market is experiencing a breath of fresh air when it comes to growth. According to projections, the market is poised to reach a substantial USD 27 billion by 2033, surging from a value of USD 11.73 billion in 2023. This robust expansion is fueled by a projected Compound Annual Growth Rate (CAGR) of 8.6%.

Key Trends and Highlights in the Anaesthesia Machines Market

A noticeable shift in the anaesthesia machines landscape is the increasing portability and compactness of these devices, enabling their use in remote and underserved areas, as well as ambulatory surgery centres.

The rising preference for non-invasive and minimally invasive medical procedures, characterized by their low risk and faster recovery times, is a prominent driver of demand. As these procedures gain popularity, there is an expected surge in the demand for anaesthesia machines that support these advanced techniques.

Request a Sample Copy of the Report Now

Continuous advancements in the design of anaesthesia machines have been observed to improve operating efficiency, patient safety, outcome, and convenience. Market participants are concentrating on new product development and the launch of innovative products with enhanced features and capabilities.

Anesthesia apparatuses are medical devices used to deliver anaesthesia to patients during surgical or other medical procedures. These machines are designed to deliver a precisely controlled mixture of gases, including oxygen, nitrous oxide, and various anaesthetic agents, to the patient’s lungs.

The research report “Anaesthesia Machines Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” published by Future Market Insights throws light on several aspects driving the global market. The growth of the market is impacted by various trends, developments, drivers and challenges, the analysis of which is included in the fact-based research report. The exhaustive research publication covers historical data analysis along with current scenarios as well as future projections of the market from a value standpoint for 10 years, starting from 2017 till 2027. The analysis of various segments playing a major role in the expansion of the global anaesthesia market has been carried out to get a complete picture of the global market.

Increasing Need for Anaesthesia Procedures to Spur the Adoption of Anaesthesia Machines in the Coming Years

According to WHO (World Health Organization) and World Bank, by 2026, the treatments demanding surgeries and hence anaesthesia machines would eclipse that of tuberculosis and HIV as well as malaria. The current market scenario portrays the fact that about 30% of the population in the entire globe does not have access to surgeries. On the contrary, about 75% of major procedures are being performed in the wealthiest countries in the world whereas poor countries are witnessing only 3.5% of operations.

Government bodies along with non-government institutions are continuously working on offering healthcare access to every region, which is expected to trigger the adoption of anaesthesia machines. The growing number of surgeries and increasing government support are expected to fuel the growth of the anaesthesia machines market at a global level in the years to follow.

However, product recalls due to defects in devices, shortage of healthcare professionals, adoption of refurbished machines, lack of public access to healthcare facilities and lack of clinical resources are expected to pose hindrances to the growth of the global market.

Segmental Highlights on the Anaesthesia Machines Market

Concerning region, North America and Asia Pacific excluding Japan (APEJ) are expected to showcase high growth potential. The Anaesthesia machines market in North America (led by the US) is estimated to be the largest, whereas the market in APEJ is expected to rise at a comparatively high-value CAGR during the forecast period
Concerning modality, standalone anaesthesia machines are expected to witness increased adoption across the globe in several hospitals and clinics. This segment is expected to lead the global market with a high valuation and is projected to expand at a relatively high CAGR throughout assessment

Access Exclusive Market Insights – Purchase Now!

Anaesthesia Machines Market Key Segments Covered:

By Modality

Standalone Anaesthesia Machines
Portable Anaesthesia Machines

By End User

Hospitals
Surgical Ambulatory Centres
Clinics
Nursing Facilities

About Future Market Insights (FMI)

Contact Us:

Ambulatory Surgical Centers Market Poised to Reach USD 150.6 Billion by 2033 at a 4.5% of CAGR

The global ambulatory surgical centers (ASCs) market has achieved substantial growth, reaching USD 96.5 billion in 2023 and expected to expand to USD 150.6 billion by 2033, demonstrating a steady compound annual growth rate (CAGR) of 4.5% over the forecast period. This growth is driven by the inherent benefits of ASCs in maximizing efficiency, reducing unnecessary services, and lowering treatment costs compared to traditional inpatient settings.

ASCs, also known as outpatient surgical centers, offer a cost-effective alternative for a wide range of medical procedures, benefiting managed care companies, self-insured employers, and government payers. The streamlined operational model of ASCs allows for reduced overhead, administrative expenses, and facility development costs compared to hospitals, translating into lower procedure costs for patients and healthcare payers.

The increasing demand for ASCs is a testament to their ability to provide efficient and affordable healthcare solutions. As the healthcare industry continues to evolve, ASCs are playing a pivotal role in delivering patient-centered care while reducing the overall financial burden on patients and healthcare systems.

Request a Sample Copy of This – Report Now

The ASCs offer adequate treatments to cure illnesses, along with providing many facilities including reimbursement policies and insurance options. Thus, providing a cost-effective treatment to patients, lower than the expenses incurred at hospitals.

At ASCs, physicians are in a better position to control expenses and patient experience. By concentrating on one specialty and owning the equipment, it becomes easier for healthcare providers to schedule procedures and run an operating room efficiently. Therefore, more physicians are opening up ASCs to cater to the growing demand for surgical procedures. Going forward, the ambulatory surgical centers market is being governed by the research and development activities initiated by key players for the advancement of the market.

Key Takeaways from the Ambulatory Surgical Centers Market:

The U.S. market is predicted to maintain its prominent position over the forecast period as well, and reach US$ 73.5 billion by 2033. The market is predicted to record a CAGR of 4.5% from 2023 to 2033.
In Asia Pacific, Japan is estimated to attain US$ 5.7 billion by 2033. The market valuation of Japan is significant than China, which attained US$ 5.3 billion in the same year.
However, the growth of the market in China is projected to be 5% CAGR, greater than the 2.4% CAGR estimated for the market in Japan.
Over the forecast period, the surgical services segment is projected to emerge as the leading service, recording a CAGR of 4.6%.The
Increasing number of ASCs delivering high-quality outpatient surgical care is projected to contribute towards the progress of this segment.

Customization – Available

News Featuring Market Developments by Key Players of Ambulatory Surgical Centers:

In January 2023, Hudson Medical Center, a US$50 million and 1, 60,000 square foot facility, opened its gates for patients. At the same premises, the first ASC in St. Croix County, named Valley Surgery Center, will also be present. The center will be able to operate about 10,000 surgeries every year, after its commencement.
In August 2022, HCA Healthcare, a major healthcare provider in the U.S., announced its acquisition of Stone Oak Surgery Center, in association with 11 physician partners. The latter is a San Antonio-based ASC, authorized by the Centers for Medicare & Medicaid Services (CMS), and offers multispecialty services. With this acquisition, HCA Healthcare will extend its footprint in San Antonio.
Earlier, in January 2022, the company had revealed its decision to develop five new hospitals, offering all the necessary services in Texas. With this initiative, the company aims to cater to the rising need for healthcare services in the state.

Key Companies Profiled:

AmSurg Corp
Tenet Healthcare
HCA Holdings, Inc.
Surgical Care Affiliates, Inc.
Surgery Partners
Ambulatory Surgical Centers of America
Pinnacle III
Proliance Surgeons
Regent Surgical Health
SurgCenter Development

Ambulatory Surgical Centers Market by Category

By Centers Type:

Single Specialty Centers
MultiSpecialty Centers

By Modality:

Hospital-Based Ambulatory Surgical Center
Freestanding Ambulatory Surgical Center

By Services:

Diagnostic Services
Surgical Services

By Specialty Area:

Gastroenterology
Ophthalmology
Orthopedics
Pain/Neurology
Urology
Dermatology
Others

Get Full Market Analysis Now – Purchase The Report

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube